[1]
Saber A. Sakr, Nahed S. Bassely, Mona A. Sakr, Mahmoud Moawad and Hassan M. Ahmed 2013. Immunohistochemical alterations in hepatocellular carcinoma patients treated with doxorubicin. World Journal of Pharmaceutical Sciences. 1, 2 (Jul. 2013), 28–38.